ESPERION THERAPEUTICS INC NE - NOTE 4.000%11/1

CUSIP: 29664WAB1

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class
Debt / NOTE 4.000%11/1
Market price (% of par)
52.75%
Total 13F principal
$199,553,764
Principal change
+$199,553,764
Total reported market value
$115,520,638
Number of holders
17
Value change
+$115,520,638
Number of buys
17

Quarterly Holders Quick Answers

What is CUSIP 29664WAB1?
CUSIP 29664WAB1 identifies 29664WAB1 - ESPERION THERAPEUTICS INC NE - NOTE 4.000%11/1 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of ESPERION THERAPEUTICS INC NE - NOTE 4.000%11/1 as of Q4 2021

As of 31 Dec 2021, ESPERION THERAPEUTICS INC NE - NOTE 4.000%11/1 was held by 17 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $199,553,764 in principal (par value) of the bond. The largest 10 bondholders included Pentwater Capital Management LP, LAZARD ASSET MANAGEMENT LLC, Davidson Kempner Capital Management LP, WHITEBOX ADVISORS LLC, TENOR CAPITAL MANAGEMENT Co., L.P., HIGHBRIDGE CAPITAL MANAGEMENT LLC, AMERIPRISE FINANCIAL INC, MORGAN STANLEY, BlueCrest Capital Management Ltd, and Point72 Asset Management, L.P.. This page lists 17 institutional bondholders reporting positions for the Q4 2021 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.